 |
인쇄하기
취소
|
Chong Kun Dang and MSD Korea’s sales partnership for allergic rhinitis treatment
On the 26th, Chong Kun Dang(CEO Young-Joo Kim) announced a co-marketing agreement of ‘Nasonex,’ a allergic rhinitis treatment, with MSD Korea.
The agreement will allow Chong Kun Dang to exclusively sell and market Nasonex in Korea from January next year.
Nasonex, an original product containing mometasone furoate, is an allergic rhinitis treatment in a form of nasal spray. It features the ra...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.